WELLFISH DIAGNOSTICS
Sustainable Aquaculture | United Kingdom | Series A | 2023
Wellfish Diagnostics is a Scottish-based, fish diagnostics business, currently offering rapid fish health assessment for the aquaculture industry through blood-based clinical chemistry analysis. The Company has a fast growing, proprietary database of fish blood biomarkers, leveraging machine learning models to enable data informed and pre-emptive decision-making for fish farmers and vets. Wellfish represents a key tool for the monitoring and improvement of fish welfare and the reduction of mortality rates across multiple species and aquaculture systems globally.
Praesidium led the 2023 Series A round and will support Wellfish on its continued roll out across salmon aquaculture, as well as expansion into new fish species and geographies.
